American Corneal Consultants, PLLC – Trademark Portfolio
Entity Type: 16
American Corneal Consultants, PLLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include LIQUID ANALYTICS. The owner is based in North Oaks, MN.
15 Island Road
North Oaks, MN 55127
Showing of trademarks Trademarks
Trademark Classifications
American Corneal Consultants, PLLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does American Corneal Consultants, PLLC have?
American Corneal Consultants, PLLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does American Corneal Consultants, PLLC file in?
American Corneal Consultants, PLLC files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are American Corneal Consultants, PLLC's most well-known trademarks?
American Corneal Consultants, PLLC's registered trademark portfolio includes well-known marks such as LIQUID ANALYTICS. These are among 1 currently registered trademark in the portfolio.
What is American Corneal Consultants, PLLC's trademark registration success rate?
American Corneal Consultants, PLLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.